相关实验视频

Updated: Jun 17, 2025

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells

Published on: March 28, 2025

针对线粒体损伤:为免疫治疗提供了新的视角

Wenjuan Zeng^1,2, Menghui Wang^1,2, Yuxin Zhang³

¹Department of Gastrointestinal Surgery, The 2Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.

Frontiers in immunology

|August 6, 2024

概括

线粒体损伤通过影响免疫系统和瘤微环境,使癌症恶化. 保护线粒体或调节巨细胞等免疫细胞可能会改善癌症治疗结果.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
细胞生物学细胞生物学

背景情况:

线粒体损伤显著影响癌症的进展.
它破坏了免疫细胞的功能,并促进了瘤微环境中的炎症.
了解这些相互作用对于开发有效的癌症治疗至关重要.

研究的目的:

阐明线粒体功能障碍,免疫系统和瘤微环境之间的复杂关系.
突出针对线粒体完整性和免疫细胞功能的癌症治疗潜力.

主要方法:

这项研究是对现有文献的综述.
它综合了癌症免疫学中线粒体功能障碍的当前研究.
专注于细胞压力,炎症和免疫反应之间的相互作用.

主要成果:

线粒体损伤通过损害免疫监测加速瘤的进展.
它会触发炎症反应,从而创造出有利于瘤的环境.
免疫细胞功能障碍,特别是巨细胞,是关键的后果.

结论:

维护线粒体完整性是一种潜在的治疗策略.
调节免疫细胞功能,如巨细胞的功能,可以提高癌症治疗的疗效.
对线粒体-免疫系统-瘤微环境相互作用的进一步研究对于新疗法开发至关重要.

关键词:

免疫细胞免疫细胞免疫疗法免疫疗法线粒体损伤可能导致线粒体损伤.目标目标目标目标目标目标目标.瘤微环境是一个微环境.

更多相关视频

Real-time Monitoring of Mitochondrial Respiration in Cytokine-differentiated Human Primary T Cells

Real-time Monitoring of Mitochondrial Respiration in Cytokine-differentiated Human Primary T Cells

Published on: October 19, 2021

Measurement of Mitochondrial Mass and Membrane Potential in Hematopoietic Stem Cells and T-cells by Flow Cytometry

Measurement of Mitochondrial Mass and Membrane Potential in Hematopoietic Stem Cells and T-cells by Flow Cytometry

Published on: December 26, 2019

相关概念视频

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...